… a movement disorder specialist at the Seattle Health Care System – Puget Sound Hospital.    View a transcript of this …

… GDNF. Biochemical markers of nasal damage and immune system activation will be measured in nasal fluid taken six … of Parkinson’s Disease: GDNF cannot enter the brain after systemic administration, and the surgery to inject it …

… Description: We have searched for new drugs using model systems in which we can study the effect of many molecules … receptors in neurons in the same fashion as in our tests systems. The second experiment to be performed will be to …

… synuclein aggregates appear in the enteric nervous system prior to brainstem involvement and may define early … synuclein pathology in the autonomic and central nervous systems. We will undertake this by creating chronic …

… proposed strategy addresses these issues via an EEG-based system that is potentially easy to use and low cost. … were still idiopathic RBD. We developed a classification system and a procedure for performance evaluation close to …

… results from a phase II trial employing another delivery system showed no clinical improvement after six months. … GDNF’s therapeutic potential as well as potential delivery system variables. Full funding for the project is contingent …